Who Paid My Doc
A Phase 2, Multicenter, Randomized, Double-Blind,
Research payments
$298,361
Through program year 2021, $298,361 in research payments was reported against A Phase 2, Multicenter, Randomized, Double-Blind,, across 29 payments, paid by Celgene Corporation.
- Paid by
- Celgene Corporation
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $298,361 | 29 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Wambui MacHua Atlanta, GA Named on 3 payments
- Swati Bharadwaj Phoenix, AZ Named on 2 payments
- Arezou Khosroshahi Atlanta, GA Named on 2 payments
- Victoria Werth Philadelphia, PA Named on 2 payments
- Fotios Koumpouras New Haven, CT Named on 2 payments
- David Karp Dallas, TX Named on 2 payments
- Guillermo Valenzuela Plantation, FL Named on 2 payments
- Anca Askanase New York, NY Named on 2 payments
- Nancy Olsen Hershey, PA Named on 1 payment
- Violeta Rus Baltimore, MD Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.